subject expert committee

Centre’s Expert Panel Recommends Regular Market Approval for Covishield, Covaxin

10 Questions the Indian Govt Must Answer About Vaccines for Minors and Boosters

Expert Panel Recommends Emergency-Use Okay for Covaxin in 2-18 Age Group

India Refuses Emergency Use License for One-Dose Sputnik

DCGI Expert Panel Recommends Against SII’s Proposal for Covovax Trial on Children

Dr Reddy’s Revealed More About 2-DG, and Its Approval Is More Confusing Now

In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us